Sort   by:  
 Page size 
UnknownImpaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible.
Not available
S-EPMC6161491 | biostudies-literature
UnknownVariation in PTX3 is associated with primary graft dysfunction after lung transplantation.
Not available
S-EPMC3480532 | biostudies-literature
UnknownPost-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Not available
S-EPMC11381616 | biostudies-literature
UnknownSafety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Not available
S-EPMC10150320 | biostudies-literature
UnknownEffect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC9941969 | biostudies-literature
UnknownBaseline differences in the HF-ACTION trial by sex.
Not available
S-EPMC3748941 | biostudies-literature
UnknownN-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.
Not available
S-EPMC3748954 | biostudies-literature
UnknownThe relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure.
Not available
S-EPMC2762950 | biostudies-literature
UnknownNew York Heart Association functional class predicts exercise parameters in the current era.
Not available
S-EPMC2762947 | biostudies-literature
UnknownMyocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial.
Not available
S-EPMC2908486 | biostudies-literature
Sort   by:  
 Page size